1-4 of 4
Venugopalan Cheriyath
Close
Sort by
Journal Articles

Consequences of UTX Dysfunction in Myelodysplastic Syndrome

Anna M Jankowska, PhD, Hadrian Szpurka, PhD, Venugopalan Cheriyath, PhD, Kwok Peng Ng, PhD, Zhenbo Hu, MD, Michael A McDevitt, MD, Yogen Saunthararajah, MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2427.
https://doi.org/10.1182/blood.V118.21.2427.2427
Published: 2011
Journal Articles

EZH2 Is Either Mutated or Downregulated in Patients with Loss of Heterozygosity of Chromosome 7/7q and Leads to Epigenetic Dysregulation Via Histone H3K27.

Hideki Makishima, MD, PhD, Shahper N Khan, PhD, Anna M Jankowska, PhD, Yuka Sugimoto, MD, Zhenbo Hu, MD, Venugopalan Cheriyath, PhD, Reda Mahfouz, MD, Quteba Ebrahem, MD, Sergei Vatolin, PhD, Yogen Saunthararajah, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P Maciejewski, MD, PhD, FACP
Journal: Blood
Blood (2011) 118 (21): 228.
https://doi.org/10.1182/blood.V118.21.228.228
Published: 2011
Journal Articles

GSK-3β Inhibitors In Overcoming Chemoresistance In Multiple Myeloma

Melissa A Kuhns, Matt Kalaycio, MD, Frederic J. Reu, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Venugopalan Cheriyath, Ph, D.
Journal: Blood
Blood (2010) 116 (21): 3009.
https://doi.org/10.1182/blood.V116.21.3009.3009
Published: 2010
Journal Articles

HDAC Inhibitor Plus Doxorubicin Combinations Reverse Apoptosis Resistance in Myeloma Cells by Triggering Cathepsin-Mediated Bax Activation

Venugopalan Cheriyath, Dustin G Thomas, Rachid Baz, MD, Matt Kalaycio, Ernest Borden
Journal: Blood
Blood (2008) 112 (11): 3661.
https://doi.org/10.1182/blood.V112.11.3661.3661
Published: 2008